Patents by Inventor Hitoshi SHIMANO

Hitoshi SHIMANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipotoxicity relieving agent
    Patent number: 8697749
    Abstract: In view of the situation that a clinically acceptable medical agent which has the action of preventing and relieving the lipotoxicity with no significant side effects is not yet provided, such medical agent is provided. An agent for relieving lipotoxicity which comprises an unsaturated fatty acid containing 18 to 22 carbon atoms and having a degree of unsaturation of 3 to 6 or a derivative thereof as its effective component.
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: April 15, 2014
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Hitoshi Shimano, Toyonori Kato
  • Nonhuman transgenic animal as type 2 diabetes model
    Publication number: 20090320147
    Abstract: The invention provides a non-human transgenic animal as a model of type 2 diabetes manifesting a symptom of type 2 diabetes by excessive expression of the active SREBP-2 protein in pancreatic ?-cells by introducing a recombinant DNA in which a DNA encoding the active SREBP-2 protein is disposed under the control of a promoter, and a method for screening therapeutic agents of diabetes using the transgenic animal.
    Type: Application
    Filed: April 8, 2005
    Publication date: December 24, 2009
    Inventors: Hitoshi Shimano, Nobuhiro Yamada
  • LIPOTOXICITY RELIEVING AGENT
    Publication number: 20090209644
    Abstract: In view of the situation that a clinically acceptable medical agent which has the action of preventing and relieving the lipotoxicity with no significant side effects is not yet provided, such medical agent is provided. An agent for relieving lipotoxicity which comprises an unsaturated fatty acid containing 18 to 22 carbon atoms and having a degree of unsaturation of 3 to 6 or a derivative thereof as its effective component.
    Type: Application
    Filed: April 28, 2009
    Publication date: August 20, 2009
    Inventors: Hitoshi SHIMANO, Toyonori KATO
  • Lipotoxicity Relieving Agent
    Publication number: 20080200707
    Abstract: In view of the situation that a clinically acceptable medical agent which has the action of preventing and relieving the lipotoxicity with no significant side effects is not yet provided, such medical agent is provided. An agent for relieving lipotoxicity which comprises an unsaturated fatty acid containing 18 to 22 carbon atoms and having a degree of unsaturation of 3 to 6 or a derivative thereof as its effective component.
    Type: Application
    Filed: January 4, 2006
    Publication date: August 21, 2008
    Applicant: MOCHIDA-PHARMACEUTICALS PHARMACEUTICAL CO., LTD.
    Inventors: Hitoshi Shimano, Toyonori Kato